
USFDA APPLICATION NUMBER - 209830 / DOSAGE - SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR - 675MG/2.4ML (281.25MG/ML)
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| aripiprazole lauroxil(UNII: B786J7A343) (aripiprazole lauroxil - UNII:B786J7A343) | aripiprazole lauroxil | 675mg in 2.4 |
Inactive Ingredients
| Ingredient Name | Alkermes, Inc. |
|---|---|
| Polysorbate 20(7T1F30V5YH) | |
| Sodium Chloride(451W47IQ8X) | |
| Sodium Phosphate, Dibasic, Anhydrous(22ADO53M6F) | |
| Sodium Phosphate, Monobasic, Dihydrate(5QWK665956) | |
| Trisodium Citrate Dihydrate(B22547B95K) | |
| Water(059QF0KO0R) |